Abiraterone acetate (Yonsa®) Patient Selection and Management PQI

Download PQI pdf 1.41MB

Last Updated: September 10, 2025

By: Atlanticare Cancer Care Institute | Cancer Specialists of North Florida

About this PQI in Action

This PQI in Action highlights how multidisciplinary oncology teams use the Yonsa® (abiraterone acetate) PQI to improve care for patients with advanced prostate cancer. Featuring insights from AtlantiCare Cancer Care Institute and Cancer Specialists of North Florida, the article shows how medically integrated pharmacy teams streamline access, educate patients, manage side effects, and ensure safe, effective, and patient-centered treatment.

Frequently Searched

Supported by

Abiraterone acetate (Yonsa®) Patient Selection and Management PQI

About this PQI in Action

More About This PQI in Action

PQI: Abiraterone acetate (Yonsa®) Patient Selection and Management